Washington, D.C.—Each spring, industry members visit lawmakers in Washington, D.C. to help ensure our laws continue to guarantee access to natural products. The Natural Products Association (NPA, npainfo.org), based in D.C., coordinates these visits by making appointments for association members with their Congressmen and women. This year, nearly 150 members representing 33 states plus the District of Columbia came to Capitol Hill for more than 140 meetings on Tuesday, March 23rd.
Silver Spring, MD—The U.S. Food and Drug Administration (FDA) recently issued a warning to consumers about the potential dangers of ear candles, and is attempting to enforce regulations on the product’s major manufacturers.
Washington, D.C.—In the wake of the filing of a lawsuit against fish oil manufacturers over alleged polychlorinated biphenyl (PCB) contamination in their products, the Council for Responsible Nutrition (CRN), based here, released a statement defending the practices of these companies.
Port-au-Prince, Haiti—Last month, WholeFoods covered efforts by industry companies to help those affected by the earthquake that hit Port-au-Prince, Haiti in January. Since the time of that publication, several other companies have offered their support:
Arlington Heights, IL—Founded by John and Susan Carlson in 1965, Carlson Laboratories, still a family-owned and -operated business, is proud to celebrate its 45th anniversary. The Carlson family was aware of the powerful antioxidant benefits associated with vitamin E, especially in the d-alpha-tocopheryl succinate form.
Washington, D.C.—Last month, WholeFoods reported on proposed legislation sponsored by Arizona Senator John McCain (R-AZ) that would redefine dietary supplements and place new burdens on the dietary supplement industry. In the weeks that followed, several industry companies and associations responded to the Dietary Supplement Safety Act (DSSA, S3.002) in full force.
Rockville, MD—The U.S. Food and Drug Administration (FDA) would like to see some extra funding in FY 2011: $146 million from the government and $601 million in industry user fees. This 23% total increase (from $3.28 billion to $4.03 billion in all) will be invested in much-needed initiatives to protect public health. Specifically, FDA hopes to use this money to benefit food safety practice, medical product safety and regulatory science.